The demand for animal protein in Nigeria is so high that introduction of new management techniques to improve poultry production is relevant. This study investigated the effects of in ovo administration of arginine on hatching traits and post-hatch performance of FUNAAB-Alpha chickens in two housing types. A total of 528 hatching eggs of FUNAAB-Alpha chickens were used for the study for 11 weeks. Hatching eggs were sorted, balanced for weight and fumigated before setting in the incubator. On the 14th day of incubation 378 eggs were confirmed fertile and they were redistributed into 3 treatment groups (0, 11 and 22 mg of arginine/egg) each consisting 126 eggs, replicated 14 times (9 eggs per replicate). At the 18th day of incubation, in ovo injection of arginine was carried out and at the 21st day of incubation, resulting chicks were balanced for weight, assigned to treatments and assessed for post-hatch performance. The experiment was laid out in a completely randomised design. In the results, hatchability was 92.86% (control), 88.39% (injection with 11 mg of arginine) and 91.07% in birds resulting from in ovo injection of 22 mg of arginine. In ovo injection of 11 and 22 mg of arginine improved the development of duodenal villi in the birds. In ovo injection of 22 and 11 mg of arginine enhanced CMIR after 24 (0.300 mm) and 48 h (0.223 mm) of injecting phytohaemagglutinin type P (PHA-P) antigen. Birds on outdoor run had higher (0.282, 0.224 mm) CMIR after 24 and 48 h of injecting PHA-P relative to those raised in deep litter housing. Birds from in ovo injection of 22 mg of arginine had a significantly lowered daily feed intake (68.38 g/bird) relative to other treatments. Deep litter housing significantly (p < 0.05) improved daily weight gain (25.02 g/bird) of birds as against outdoor run (22.62 g/bird). It was concluded that in ovo injection of 11 or 22 mg of arginine numerically improved hatchability and cell-mediated immune response with enhanced duodenal villi development, while in ovo injection of 22 mg of arginine and raising resulting birds on outdoor run is suitable for achieving significantly lower feed intake with better feed conversion ratio in FUNAAB-Alpha chickens.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11250-020-02258-x | DOI Listing |
J Anim Physiol Anim Nutr (Berl)
December 2024
Department of Animal Biotechnology and Genetics, Bydgoszcz University of Science and Technology (PBS), Bydgoszcz, Poland.
The presented study explored the promising alternatives of in ovo injection with Lactiplantibacillus plantarum (LP) and galactooligosaccharide (GOS) in the poultry industry. The study aimed to assess the effects of probiotic and prebiotic on various aspects of poultry production. The study involved 300 Ross broiler eggs, individually candled on Day 7 of embryonic development.
View Article and Find Full Text PDFPoult Sci
December 2024
Queensland Alliance for Agriculture and Food Innovation (QAAFI), The University of Queensland, Australia. Electronic address:
The early post-hatching phase remains to be one of the most vulnerable phases in broiler production. Some essential oils have been reported to improve gut health and growth in broiler chickens when applied to post-hatching diets. However, in-feed applications are unable to prevent the health challenges observed immediately after hatching.
View Article and Find Full Text PDFHum Reprod
November 2024
Department of Obstetrics and Gynecology, University of Montreal, Montreal, QC, Canada.
Study Question: Does adjuvant growth hormone (GH) therapy in GnRH antagonist cycles improve reproductive outcomes in the general IVF population?
Summary Answer: Empiric adjuvant GH therapy in GnRH antagonist cycles does not improve IVF stimulation results or reproductive outcomes, including implantation, miscarriage, and clinical pregnancy rates.
What Is Known Already: Previous evidence regarding the benefits of GH therapy in IVF cycles has been inconclusive due to the lack of well-designed, large-scale randomized controlled trials (RCTs) in the general IVF population.
Study Design, Size, Duration: This is a phase III open-label RCT involving 288 patients undergoing antagonist IVF cycles at the Ovo clinic in Montreal, Canada, between June 2014 and January 2020.
J Appl Genet
December 2024
Department of Animal Biotechnology and Genetics, Bydgoszcz University of Science and Technology (PBS), Mazowiecka 28, 85-084, Bydgoszcz, Poland.
A stable gut microbiota promotes a healthy gut and enhances immune function, antioxidant status, and metabolic activities in chickens. The present research work aimed to investigate the modulatory impacts of in ovo delivery of prebiotic and probiotic on oxidative stress, the intestinal transcriptome, and various plasma metabolites in chickens. Fertilized Ross 308 eggs were administered in ovo either with galactooligosaccharide (GOS) (3.
View Article and Find Full Text PDFNature
December 2024
Laboratory of Artificial & Natural Evolution (LANE), Department of Genetics & Evolution, University of Geneva, Geneva, Switzerland.
Amniote integumentary appendages constitute a diverse group of micro-organs, including feathers, hair and scales. These structures typically develop as genetically controlled units, the spatial patterning of which emerges from a self-organized chemical Turing system with integrated mechanical feedback. The seemingly purely mechanical patterning of polygonal crocodile head scales provides an exception to this paradigm.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!